StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
H. Lundbeck A/S
Copenhagen Stock Exchange:HLUN-B.CO
Sector
Location
Market Cap
USD 5.36 B
Share Price
USD 5.57
Avg Daily Volume
590,266
Change (1 day)
0.58%
Change (1 year)
-3.73%
Change (YTD)
-3.15%
H. Lundbeck A/S Shareholders' Equity for the year ending December 31, 2024: USD 3.46 B
H. Lundbeck A/S Shareholders' Equity is USD 3.46 B for the year ending December 31, 2024, a 6.08% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
H. Lundbeck A/S Shareholders' Equity for the year ending December 31, 2023 was USD 3.26 B, a 9.43% change year over year.
-
H. Lundbeck A/S Shareholders' Equity for the year ending December 31, 2022 was USD 2.98 B, a 6.73% change year over year.
-
H. Lundbeck A/S Shareholders' Equity for the year ending December 31, 2021 was USD 2.79 B, a 0.49% change year over year.
-
H. Lundbeck A/S Shareholders' Equity for the year ending December 31, 2020 was USD 2.78 B, a 27.61% change year over year.
Competitors
Eli Lilly and Company
USD 777.66
LLY
+4.79
0.62%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
Cencora, Inc.
USD 298.03
COR
-4.47
-1.48%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.44
600276.SS
+0.11
1.44%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Haleon plc
USD 5.04
HLN.L
-0.01
-0.16%
Daiichi Sankyo Company, Limited
USD 21.88
4568.T
+0.50
2.33%
Ucb S.A.
USD 199.43
UCB.BR
+0.52
0.26%
Hansoh Pharmaceutical Group Company Limited
USD 4.00
3692.HK
+0.10
2.47%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
Eli Lilly and Company
USD 777.66
LLY
+4.79
0.62%
AbbVie Inc.
USD 189.77
ABBV
+2.14
1.14%
Roche Holding AG
USD 342.36
RO.SW
+0.11
0.03%
AstraZeneca PLC
USD 140.42
AZN.L
+1.47
1.06%
Merck & Co., Inc.
USD 81.37
MRK
+0.47
0.58%
Amgen Inc.
USD 297.00
AMGN
+4.05
1.38%
Pfizer Inc.
USD 25.62
PFE
+0.38
1.51%
Gilead Sciences, Inc.
USD 111.06
GILD
-0.72
-0.64%
Sanofi
USD 97.70
SAN.PA
+1.18
1.22%
Bristol-Myers Squibb Company
USD 47.04
BMY
+0.55
1.18%
Chugai Pharmaceutical Co., Ltd.
USD 46.38
4519.T
-0.70
-1.48%
GSK plc
USD 19.20
GSK.L
+0.23
1.19%
Regeneron Pharmaceuticals, Inc.
USD 547.75
REGN
+9.64
1.79%
Cencora, Inc.
USD 298.03
COR
-4.47
-1.48%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.44
600276.SS
+0.11
1.44%
Takeda Pharmaceutical Company Limited
USD 29.98
4502.T
+0.01
0.04%
Haleon plc
USD 5.04
HLN.L
-0.01
-0.16%
Daiichi Sankyo Company, Limited
USD 21.88
4568.T
+0.50
2.33%
Ucb S.A.
USD 199.43
UCB.BR
+0.52
0.26%
Hansoh Pharmaceutical Group Company Limited
USD 4.00
3692.HK
+0.10
2.47%